Mirae Asset Global Investments
CGEM icon

Mirae Asset Global Investments’s Cullinan Oncology CGEM Stock Holding History

Mirae Asset Global Investments’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.1K Sell
2,749
-332
-11% -$4.93K ﹤0.01% 1354
2026
Q1 		$43.8K Buy
3,081
+210
+7% +$2.7K ﹤0.01% 1320
2025
Q4 		$29.7K Buy
2,871
+587
+26% +$5.29K ﹤0.01% 1489
2025
Q3 		$13.5K Buy
2,284
+4
+0.2% +$29 ﹤0.01% 1540
2025
Q2 		$17.2K Buy
2,280
+306
+16% +$2.46K ﹤0.01% 1417
2025
Q1 		$15.8K Buy
1,974
+34
+2% +$326 ﹤0.01% 1410
2024
Q4 		$23.3K Sell
1,940
-157
-7% -$2.26K ﹤0.01% 1400
2024
Q3 		$36K Buy
2,097
+376
+22% +$6.67K ﹤0.01% 1358
2024
Q2 		$29.4K Sell
1,721
-15,548
-90% -$331K ﹤0.01% 1331
2024
Q1 		$209K Buy
17,269
+3,134
+22% +$48.4K ﹤0.01% 2245
2023
Q4 		$144K Buy
14,135
+64
+0.5% +$567 ﹤0.01% 2396
2023
Q3 		$127K Buy
14,071
+114
+0.8% +$1.19K ﹤0.01% 2413
2023
Q2 		$150K Sell
13,957
-80
-0.6% -$850 ﹤0.01% 2421
2023
Q1 		$144K Sell
14,037
-188
-1% -$2.07K ﹤0.01% 2391
2022
Q4 		$150K Buy
14,225
+20
+0.1% +$243 ﹤0.01% 2366
2022
Q3 		$183K Buy
+14,205
New +$191K ﹤0.01% 2369

Other funds holding CGEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mirae Asset Global Investments's CGEM Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Cullinan Oncology (CGEM) stake by 11% in Q2 2026, selling an estimated $4.93K and leaving 2,749 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Mirae Asset Global Investments first reported a position in CGEM in Q3 2022 and has held it in 16 quarters since. The position peaked at $209K in Q1 2024. 50 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Mirae Asset Global Investments held 2,749 shares of Cullinan Oncology worth $50.1K as of Q2 2026.
  • Mirae Asset Global Investments sold 332 Cullinan Oncology shares in Q2 2026, an estimated $4.93K.
  • Cullinan Oncology made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1354 holding.
  • Mirae Asset Global Investments first reported a position in Cullinan Oncology in Q3 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Cullinan Oncology position peaked at $209K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.